Allelic Gain and Amplification on the Long Arm of Chromosome 17 in Anaplastic Meningiomas

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain Pathology

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1750-3639.2002.tb00429.xPMID 11958368PMCID PMC8095877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PS6K amplification characterizes a small subset of anaplastic meningiomas.

  2001influential reference
• A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization.

  2001cited by this paper
• The tumour suppressor protein NF2/merlin: the puzzle continues.

  2001cited by this paper
• Merlin, DAL‐1, and Progesterone Receptor Expression in Clinicopathologic Subsets of Meningioma: A Correlative Immunohistochemical Study of 175 Cases

  2000cited by this paper
• Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.

  2000cited by this paper
• 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.

  2000cited by this paper
• World Health Organization classification of tumors

  2000influential reference
• Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

  1999cited by this paper
• Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.

  1999cited by this paper
• 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification

  1999cited by this paper
• "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

  1999cited by this paper
• Detection of gains and losses in 18 meningiomas by comparative genomic hybridization.

  1998cited by this paper
• Real-time quantitative RT–PCR after laser-assisted cell picking

  1998cited by this paper
• Four regions of allelic imbalance on 17q12‐qter associated with high‐grade breast tumors

  1997cited by this paper
• Increased copy number at 17q22‐q24 by CGH in breast cancer is due to high‐level amplification of two separate regions

  1997cited by this paper
• Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

  1997cited by this paper
• Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.

  1997cited by this paper
• Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

  1996cited by this paper
• Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.

  1995cited by this paper
• Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

  1994cited by this paper
• Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique

  1994cited by this paper

• Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas

  2023cites this paper
• Molecular genetics of meningiomas.

  2020cites this paper
• Copy number assessment in the genomic analysis of CNS neoplasia: An evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors.

  2020cites this paper
• Molecular characteristics of meningiomas

  2020cites this paper
• The Genomic Landscape of Meningiomas

  2020cites this paper
• Protein Kinase A Distribution in Meningioma

  2019cites this paper
• Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas

  2019cites this paper
• Emerging Medical Treatments for Meningioma in the Molecular Era

  2018cites this paper
• Atypical and Malignant Meningiomas

  2017cites this paper
• Genomic landscape of intracranial meningiomas.

  2016cites this paper
• Genomic and Epigenomic Landscape in Meningioma.

  2016cites this paper
• Expression and gene doses changes of the p53-regulator PPM1D in meningiomas: a role in meningioma progression?

  2016cites this paper
• Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

  2016cites this paper
• Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications

  2016cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015cites this paper
• Genetic/molecular alterations of meningiomas and the signaling pathways targeted

  2015cites this paper
• Her2neu Amplification Associates with Co-deletion 1p/14q in Recurrent Meningiomas

  2013cites this paper
• Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation

  2013cites this paper
• Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.

  2013cites this paper
• Genomic and Expression Alterations of Tumor Suppressor Genes in Meningioma Development, Progression and Recurrence

  2012cites this paper
• Badania kliniczno-molekularne w oponiakach

  2012cites this paper
• Tumor suppressor genes

  2012cites this paper
• Update on meningiomas.

  2011cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

  2011cites this paper
• WRAP53 Unwrapped; Roles in Nuclear Architecture and Cancer

  2011cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments

  2011cites this paper
• Pathology and genetics of meningiomas.

  2011cites this paper
• 1 – Pathology and Molecular Genetics of Common Brain Tumors

  2010cites this paper
• CHAPTER 6 – Neuropathology of Meningiomas

  2010cites this paper
• CHAPTER 8 – Molecular Biology and Genetics of Meningiomas

  2010cites this paper
• Pathological classification and molecular genetics of meningiomas

  2010cites this paper
• Genomic Profiling of Atypical Meningiomas Associates Gain of 1q With Poor Clinical Outcome

  2009cites this paper
• Molecular Basis of Meningioma Tumorigenesis and Progression

  2009cites this paper
• Meningioma Tumorigenesis: An Overview of Etiologic Factors

  2009cites this paper
• Tumours: non-neuroepithelial tumours and secondary effects

  2008cites this paper
• Microarray gene expression profiling in meningiomas and schwannomas.

  2008cites this paper
• Methylation-specific multiplex ligation-dependent probe amplification in meningiomas

  2008cites this paper
• Histology and Molecular Genetics

  2008cites this paper
• Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

  2008cites this paper
• Molecular genetics of meningiomas: from basic research to potential clinical applications.

  2007cites this paper
• Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus

  2007cites this paper
• [Cytogenetic alterations in meningioma tumors and their impact on disease outcome].

  2007cites this paper
• Alteraciones citogenéticas en meningiomas y su impacto en la evolución de la enfermedad

  2007cites this paper
• Childhood ALL and second neoplasms

  2007cites this paper
• Diagnostic and molecular pathology of meningiomas

  2006cites this paper
• Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.

  2006cites this paper
• Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region

  2006influential citation
• Histological classification and molecular genetics of meningiomas.

  2006cites this paper
• Cytogenetics of Meningioma: A Review

  2006cites this paper
• Microarray‐based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression

  2005cites this paper
• Molecular Diagnostics in Central Nervous System Tumors

  2005cites this paper
• Cajal bodies: a long history of discovery.

  2005cites this paper
• Meningiomas.

  2004cites this paper
• Functional significance of S6K overexpression in meningioma progression

  2004cites this paper
• Molecular pathogenesis of meningiomas

  2004cites this paper
• Meningioma Pathology, Genetics, and Biology

  2004cites this paper
• Brain tumours: classification and genes

  2004cites this paper
• Loss of Tumor Suppressor in Lung Cancer‐1 (TSLC1) Expression in Meningioma Correlates with Increased Malignancy Grade and Reduced Patient Survival

  2004cites this paper
• [The molecular genetics of meningiomas and genotypic/phenotypic correlations].

  2003cites this paper
• Meningiomas--the future: is 2020 here?

  2003cites this paper